Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
Respite from daily pricks? Hopes high for diabetics as weekly insulin dose nears global approvals
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
theprint.in